Skip to main content
. Author manuscript; available in PMC: 2023 Feb 2.
Published in final edited form as: Clin Cancer Res. 2022 Aug 2;28(15):3235–3241. doi: 10.1158/1078-0432.CCR-21-3078

Table 1.

Treatment plan

No. of
pts		 Cohort Gedatolisib Cofetuzumab Pelidotin
Dose Frequency of
administration		 Route of
administration		 Dose Frequency of
administration		 Route of
administration
4 1 110 mg D1,8,15 every 21 days IV 1.4 mg/kg D1 every 21 days IV
3 2 180 mg D1,8,15 every 21 days IV 1.4 mg/kg D1 every 21 days IV
11 3 180 mg D1,8,15 every 21 days IV 2.8 mg/kg D1 every 21 days IV